ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2023
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Start ups
    • Funding
    • Appointments
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » Companies News

Pfizer to buy Medivation for $14 billion

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Pfizer to buy Medivation for $14 billion
The merger will be for $81.50 a share in cash for a total enterprise value of approximately $14 billion. Photo: Wikipedia

Pfizer Inc has agreed to buy Medivation Inc which is a biopharmaceutical company focused on developing and commercializing in the treatment for cancer.

The merger will be for $81.50 a share in cash for a total enterprise value of approximately $14 billion.

“The Boards of Directors of both companies have unanimously approved the merger, which is expected to be immediately accretive to Pfizer’s Adjusted Diluted EPS upon closing, approximately $0.05 accretive in the first full year after close with additional accretion and growth anticipated thereafter,” the company said in a statement.

Pfizer does not expect the transaction to impact its current 2016 financial guidance.

Ian Read, chairman and chief executive officer, Pfizer said, “The proposed acquisition of Medivation is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Pfizer.”

Medivation’s portfolio includes Xtandi which is a leading novel hormone therapy in the US.

Xtandi, generated approximately $2.2 billion in worldwide net sales over the past four quarters, as recorded by Astellas Pharma Inc.

The purchase of Medivation, if approved by regulators, would be Pfizer`s biggest buy since it bought the medical device company Hospira last year for $17 billion, a report by AFP stated.

“We believe the combination with Pfizer is the right next step in our growth trajectory and is a testament to the passion and dedication by which the Medivation team has delivered on our mission to profoundly transform patients’ lives through medically innovative therapies,” said David Hung, M.D., founder, president and CEO of Medivation. 

 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
PfizerMedivationXtandiPfizer mergerIan ReadPharma
Written By: ZeeBiz WebTeam
Updated: Mon, Aug 22, 2016
06:58 pm
Mumbai, ZeeBiz WebDesk
RELATED NEWS
Pfizer plans to bring more global drugs to India Pfizer plans to bring more global drugs to India
Pfizer to buy Anacor Pharma in Rs 34,000 crore deal Pfizer to buy Anacor Pharma in Rs 34,000 crore deal
Pfizer expected to bid for acquisition of US cancer drug company Medivation Pfizer expected to bid for acquisition of US cancer drug company Medivation

LATEST NEWS

Mughal Gardens at Rashtrapati Bhavan renamed Amrit Udyan, to open for public from January 31 - How to book tickets online, price and other details

Tech Mahindra Q3 Results Preview: Net profit likely at Rs 1,300 crore with 50 bps rise in margin

Adani Group rules out changes in price, dates of FPO; company confident offer share sales going through

Budget 2023: Gems and Jewellery industry body urges government to reduce import duty on cut and polished diamonds

BPCL Q3 Results Preview: State-run oil marketing firm to report profit in December quarter on easing crude oil prices

BEL Dividend 2023 News: Check amount, record date and ex date

Budget 2023: Govt may not come up with fresh divestment plans; likely to focus on privatisation of already announced PSU firms

Odisha Health Minister Naba Das shot by cop; sustains severe injuries

Indian stock markets achieve complete transition to shorter T+1 settlement regime

Market Capitalisation Update: Seven of top-10 BSE listed firms shed Rs 2.16 lakh cr; SBI, HDFC Bank among top losers

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. India Dot Com Private Limited. All Rights Reserved.
LIVE TV